Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0000899243-22-002879

Options or other derivatives

  • See Remarks acquired 340,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Stuart Bryan See Remarks 2022-01-19 Grant or award · Stock Option (right to buy) +340,000 340,000 D
Loading xslF345X03/doc4.xml…